Clinical Trial Update: Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

This clinical trial update presents safety and preliminary efficacy data from a Phase 2 study of GLPG0634 (filgotinib) in patients with methotrexate-refractory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GLPG0634 (filgotinib) (filgotinib)

Snippet

Sponsor: Galapagos NV | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED